Memorial Sloan Kettering Cancer Center - Q2 2023 holdings

$31.7 Million is the total value of Memorial Sloan Kettering Cancer Center's 5 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .

 Value Shares↓ Weighting
GDX  VANECK ETF TRUSTgold miners etf$22,236,235
-6.9%
738,5000.0%70.19%
-4.2%
ORIC  ORIC PHARMACEUTICALS INC$4,673,631
+36.1%
602,2720.0%14.75%
+40.1%
 CARIBOU BIOSCIENCES INC$2,312,833
-20.0%
544,1960.0%7.30%
-17.6%
YMAB  Y-MABS THERAPEUTICS INC$1,298,276
+35.5%
191,1760.0%4.10%
+39.5%
ILMN  ILLUMINA INC$1,160,001
-19.4%
6,1870.0%3.66%
-17.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VANECK VECTORS ETF TR12Q3 202380.9%
ORIC PHARMACEUTICALS INC12Q3 202314.8%
Y-MABS THERAPEUTICS INC12Q3 20239.6%
CARIBOU BIOSCIENCES INC8Q2 202319.5%
ILLUMINA INC8Q2 20234.4%
ROYALTY PHARMA PLC6Q1 202275.6%

View Memorial Sloan Kettering Cancer Center's complete holdings history.

Latest significant ownerships (13-D/G)
Memorial Sloan Kettering Cancer Center Q2 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Y-mAbs Therapeutics, Inc.February 14, 2020257,5170.6%
Actinium Pharmaceuticals, Inc.February 13, 20181,230,9541.5%
Cactus Ventures, Inc.January 18, 20135,702,38734.7%

View Memorial Sloan Kettering Cancer Center's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15
13F-HR2021-08-16

View Memorial Sloan Kettering Cancer Center's complete filings history.

Compare quarters

Export Memorial Sloan Kettering Cancer Center's holdings